Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors


NCT00777504

Interventional

Phase 4

Unknown status
The purpose of this study is to determine if and how often an unexpected fast increase of disease and complaints shows after stopping the anti-angiogenetic therapy
Oct 31,2008
All
18 Years
N/A
30

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.